Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737969 · ClinicalTrials.gov registry record
TEE/Angio Fusion Study
A clinical trial of Structural Heart Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02737969 is a study of Structural Heart Disease that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02737969, a study of Structural Heart Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study of patients undergoing structural heart disease procedures that utilize TEE and fluoroscopic guidance at the New York University (NYU) Langone Medical Center. Patients in this study will undergo their procedure utilizing the TEE/Angio fusion software prototype. This protocol is primarily intended to ascertain the potential utility of the software prototype in the study population and to provide data and feedback to improve the workflow and algorithms of the prototype. As such, a primary outcome variable and statistical analysis plan have not been identified. However, procedural time, measures of radiation exposure (dose area product, total radiation dose, fluoroscopy time), degree of residual valvular regurgitation or paravalvular regurgitation as applicable, and complications will be recorded.
Conditions Studied
Interventions
- DEVICE Transesophageal Echocardiography/angiography (TEE/Angio)
Study Locations (1)
New York
- New York University Langone Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02737969
The ClinicalTrials.gov registry entry for NCT02737969 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Structural Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Transesophageal Echocardiography/angiography (TEE/Angio) is the first listed.
NCT02737969 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02737969 about?
NCT02737969 is a clinical study titled "TEE/Angio Fusion Study". This is a pilot study of patients undergoing structural heart disease procedures that utilize TEE and fluoroscopic guidance at the New York University (NYU) Langone Medical Center. Patients in this study will undergo their procedure utilizing the TEE/Angio fusion software prototype. This protocol is...
What is the current status of trial NCT02737969?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-04. Estimated completion is 2018-05-02.
What conditions does trial NCT02737969 study?
This clinical trial studies the following conditions: Structural Heart Disease.
What interventions are being tested in trial NCT02737969?
The interventions under investigation include: Transesophageal Echocardiography/angiography (TEE/Angio) (DEVICE).
Who is sponsoring clinical trial NCT02737969?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737969 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Structural Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.